Xeroderma pigmentosum

Xeroderma pigmentosum, or xeroderma pigmentosum, is a rare inherited skin disorder characterized by hypersensitivity of the skin to ultraviolet radiation. The condition is associated with a deficiency of enzymes needed for DNA repair, resulting in a high susceptibility to skin tumors. Patients experience pigment changes, keloids, and premature aging of the skin. Xeroderma pigmentosum is also considered a systemic disorder, as patients may develop other manifestations due to metabolic and cellular dysfunction.

History of the disease and interesting historical facts

The history of xeroderma pigmentosum includes several key stages. The first mentions of the disease date back to the first decade of the 20th century, when Martin K. and his colleagues described cases that corresponded to the characteristic clinical picture. One of the landmark studies was conducted in 1941 by Richard Riggs, who identified the pathogenesis of the disease. The discovery of a genetic predisposition to xeroderma pigmentosum occurred only in the 1980s, when mutations in genes responsible for DNA reparation were identified. In recent decades, the study of the disease has been actively continuing, including at the molecular genetic level, which allows not only to improve the quality of diagnostics, but also to develop new approaches to treatment.

Epidemiology

Xeroderma pigmentosum is rare and occurs in people of all ethnic groups, but is more often observed in people with a Caucasian genetic predisposition. According to statistics, the incidence of the disease varies from 1 in 250,000 to 1 in 1,000,000 newborns in the general population. Patients are more likely to develop malignant skin tumors: melanoma, basalioma, and squamous cell carcinoma. The incidence of these tumors is significantly higher than in people without xeroderma pigmentosum, which requires constant monitoring of the skin condition in these patients.

Genetic predisposition to this disease

Xeroderma pigmentosum is a hereditary disease associated with mutations in genes responsible for nucleotide excision repair. To date, several genes involved in the development of this disease have been identified, including:

• The XPA gene, which provides primary repair of damaged DNA.
• XPD gene involved in DNA repair and pH-related processes.
• The XPG gene, which is responsible for the extraction of erroneous DNA regions.
• The XPF gene plays an important role in the adequate repair process.
• XPB and XPC genes responsible for cell cycle control and regulation of apoptosis.

These mutations result in functional deficiency of DNA repair mechanisms and formation of photosensitivity. The disease is inherited in an autosomal recessive manner, which means that both parents must be carriers of the mutation for the pathology to manifest in their offspring.

Risk factors for the development of this disease

There are several risk factors that contribute to the development of xeroderma pigmentosum:

• Ultraviolet radiation: Direct exposure to sunlight is the main trigger that worsens the skin condition.
• Family history: Having patients in the family increases the likelihood of the disease developing in offspring.
• Immune disorders: Conditions that suppress the immune system may contribute to the development of the disease.
• Chemical Agents: Possible harmful agents such as UV counters or some chemicals used in manufacturing.
• Age: Symptoms may appear in early childhood, but the onset and severity of the disease often vary.

It should be noted that a combination of several factors can significantly increase the likelihood of developing the disease.

Diagnosis of this disease

Diagnosis of xeroderma pigmentosum is based on a combination of clinical picture and additional instrumental and laboratory studies:

• Main symptoms: Patients exhibit photosensitivity, pigmentation, atrophic skin changes, keratosis, and an increased predisposition to malignant neoplasms.
• Laboratory tests: An important step is molecular genetic testing for the presence of mutations in specific genes.
• Radiological tests: Imaging tests are sometimes used to evaluate the skin and detect growths.
• Other diagnostic methods: Using a skin biopsy for histological examination can help confirm the diagnosis.
• Differential diagnosis: It is necessary to differentiate xeroderma from other dermatological conditions such as alopecia, rosacea, or eczema.

Treatment

Treatment of xeroderma pigmentosum is complex and includes several areas:

• General treatment: The focus should be on preventing sunburn, which includes using sunscreens with a high protection factor.
• Pharmacological treatment: The use of antioxidants and drugs that improve skin texture may have a positive effect.
• Surgical treatment: If malignant or precancerous neoplasms are detected, surgical removal is indicated.
• Other treatments: Photodynamic therapy, laser treatment and cryotherapy are considered.

The effectiveness of treatment depends on early diagnosis and the severity of the disease.

List of medications used to treat this disease

Drugs used to treat xeroderma pigmentosum include:

• Topical antioxidants (eg, vitamin E)
• Retinoid-based drugs
• Immunosuppressive agents to prevent overgrowth
• Sunscreens with SPF 50+
• Drugs for systemic use, such as methotrexate in acute cases of the disease

The selection of drugs should be carried out individually depending on the patient's condition and his response to therapy.

Disease monitoring

Monitoring of the condition of patients with xeroderma pigmentosum includes regular check-ups and dynamic observation. Important:

• Control stages: Regular examinations by a dermatologist to assess the condition of the skin and identify neoplasms.
• Prognosis: With adequate prevention and treatment, quality of life can be significantly improved and the risk of complications can be minimized.
• Complications: Mainly associated with the development of malignant tumors, which requires constant monitoring.

Age-related features of the disease

Xeroderma pigmentosum can appear at any age, but symptoms most often begin to develop in childhood. In children and adolescents:

• The course may be more pronounced, with premature aging of the skin.
• The psychological impact is related to inferiority in the social environment.

In adult patients, the following is observed:

• With increasing age, the risk of developing malignant neoplasms increases.
• Against the background of an existing disease, concomitant diseases may develop - myopathy, neurological disorders.

Questions and Answers

• What is xeroderma pigmentosum? Xeroderma pigmentosum is a genetic disorder characterized by increased sensitivity of the skin to UV radiation and a deficiency in DNA repair mechanisms.
• How is xeroderma pigmentosum diagnosed? Diagnosis is based on clinical manifestations, molecular genetic testing and skin biopsy.
• What factors increase the risk of developing xeroderma pigmentosum? Major risk factors include family history, ultraviolet radiation, and certain chemical agents.
• How is xeroderma pigmentosum treated? Treatment includes sunscreen therapy, antioxidants, surgery and laser therapy depending on the severity of the disease.
• What is the prognosis for patients with xeroderma pigmentosum? With adequate prevention and treatment, the prognosis can be favorable, but constant monitoring is required due to the high predisposition to malignancy.